Trazodone Patient Assistance for Low-Income Patients: Programs, Discounts, and Insurance Options

Trazodone Patient Assistance for Low-Income Patients
At a glance
- Average cash price / $4 to $15 per month for generic trazodone 50 to 150 mg
- FDA approval / first approved 1981 for major depressive disorder
- Generic status / fully generic since 1986, manufactured by 10+ companies
- Medicaid coverage / covered in all 50 states on preferred drug lists
- Medicare Part D / listed on most plan formularies at Tier 1 (lowest copay)
- Retail $4 programs / available at Walmart, Kroger, Costco, and others
- 340B eligibility / dispensed at federally qualified health centers at reduced cost
- Prescription discount cards / GoodRx, RxAssist, and NeedyMeds list trazodone under $10
- State programs / 23+ states operate pharmaceutical assistance programs covering generics
Why Trazodone Is Already One of the Most Affordable Antidepressants
Trazodone lost patent exclusivity in 1986, and today more than ten manufacturers produce generic tablets in 50 mg, 100 mg, 150 mg, and 300 mg strengths [1]. That competition keeps the average retail cash price between $4 and $15 for a 30-day supply. By comparison, brand-name antidepressants such as Trintellix (vortioxetine) can exceed $500 per month without insurance [2].
How Generic Competition Drives the Price Down
The FDA Orange Book lists trazodone hydrochloride with an "A" therapeutic equivalence rating across all approved generic versions, confirming bioequivalence to the original brand Desyrel [3]. Each additional generic manufacturer added to the market has historically reduced the price by 6 to 10% according to FDA analyses of generic drug competition [4]. With more than a decade of multi-source availability, trazodone sits at commodity pricing.
Cash-Pay Benchmarks in 2026
A 30-day supply of trazodone 50 mg (one tablet nightly) averages $4.00 at Walmart, $5.47 at Costco, and $8, $12 at chain pharmacies such as CVS and Walgreens without a discount card [5]. The 100 mg and 150 mg strengths typically cost the same or within $2 of the 50 mg tablets because generic pricing is volume-driven rather than dose-driven.
Even at these low prices, cost remains a barrier for some patients. A 2023 CDC analysis found that 8.3% of U.S. Adults aged 18 to 64 did not take medications as prescribed due to cost in the prior 12 months [6]. For patients managing depression or chronic insomnia (the two primary uses of trazodone), any interruption in adherence raises relapse risk [7].
Medicaid Coverage for Trazodone
Medicaid is the single largest source of prescription drug coverage for low-income adults in the United States, covering over 90 million enrollees as of 2025 [8]. Trazodone appears on preferred drug lists in all 50 state Medicaid programs because federal rebate law requires coverage of FDA-approved generics from participating manufacturers [9].
Copay Expectations Under Medicaid
Most Medicaid plans charge $0 to $3 per generic prescription. Federal law caps copays at $4 for preferred generics for enrollees below 150% of the federal poverty level [10]. Many states have eliminated copays for behavioral health medications entirely, including trazodone, as part of mental health parity initiatives.
Medicaid Expansion and Eligibility
Under the Affordable Care Act, 40 states plus the District of Columbia have expanded Medicaid to cover adults with incomes up to 138% of the federal poverty level ($20,783 for a single adult in 2026) [8]. Adults without dependent children who previously had no coverage pathway can now enroll in expansion states. Applications are accepted year-round at state Medicaid offices or through Healthcare.gov.
Medicare Part D and the Extra Help Program
For adults 65 and older (or those under 65 with qualifying disabilities), Medicare Part D covers trazodone on most plan formularies at Tier 1, the lowest cost-sharing tier [11]. Standard Tier 1 copays range from $0 to $11 per month depending on the plan.
Low-Income Subsidy (Extra Help)
The Medicare Extra Help program (also called the Low-Income Subsidy) reduces Part D premiums, deductibles, and copays for beneficiaries with limited income and resources [12]. In 2026, eligibility thresholds are approximately $22,590 in annual income for a single individual and $30,660 for a married couple, with asset limits of $17,220 and $34,360 respectively.
Qualifying beneficiaries pay $0 for generic medications including trazodone under full Extra Help, or $4.50 per prescription under partial Extra Help [12]. The Social Security Administration processes applications, and beneficiaries can apply online at ssa.gov or by calling 1-800-772-1213.
The Inflation Reduction Act's $2,000 Cap
Starting in 2025, the Inflation Reduction Act capped total out-of-pocket Part D spending at $2,000 per year [11]. While trazodone alone rarely approaches this threshold, patients taking multiple medications benefit from the cap. Medicare also now allows beneficiaries to spread out-of-pocket costs across monthly installments through the Medicare Prescription Payment Plan.
$4 Generic Lists and Retail Discount Programs
Several major pharmacy chains and retailers maintain $4 generic drug lists that include trazodone. These programs do not require insurance and are available to any customer.
Retailers Offering Trazodone at $4 Per Month
Walmart's $4 Prescriptions Program lists trazodone 50 mg and 100 mg tablets (30-day supply) at $4 and 90-day supplies at $10 [5]. Kroger, Albertsons, and Fred Meyer operate similar programs. Costco's member pricing places trazodone under $6 for 30 tablets without requiring a Costco membership for pharmacy purchases (federal law requires pharmacies inside membership warehouses to serve non-members).
Prescription Discount Cards
GoodRx, RxSaver, and SingleCare aggregate pharmacy pricing and provide free coupons that reduce trazodone costs to $3, $9 at participating pharmacies. These cards function as a secondary discount when a patient has no insurance or when the cash/discount price is lower than the insurance copay. A 2021 study in the Journal of General Internal Medicine found that discount card prices beat insurance copays for low-cost generics in 28% of transactions analyzed [13].
340B Drug Pricing Program and Community Health Centers
The federal 340B Drug Pricing Program requires drug manufacturers to sell outpatient medications at significant discounts to eligible healthcare organizations, including federally qualified health centers (FQHCs), disproportionate share hospitals, and Ryan White HIV/AIDS clinics [14].
How 340B Pricing Works for Trazodone
Covered entities purchase trazodone at 340B ceiling prices, which are typically 25 to 50% below wholesale acquisition cost [14]. Because trazodone's wholesale cost is already low (approximately $0.03, $0.08 per tablet at 340B pricing), FQHCs can dispense it at minimal or no charge. Over 1,400 FQHCs operate across the United States, and they are required to serve patients regardless of ability to pay, using sliding-fee scales based on income [15].
Finding a 340B Pharmacy
The Health Resources and Services Administration (HRSA) maintains a searchable database of 340B-covered entities at hrsa.gov. Patients can also locate the nearest FQHC through findahealthcenter.hrsa.gov. Walk-in patients without insurance or with high-deductible plans can request 340B pricing at these facilities.
State Pharmaceutical Assistance Programs (SPAPs)
At least 23 states operate pharmaceutical assistance programs that supplement Medicare Part D or provide standalone drug coverage for low-income residents [16]. These programs go by different names in each state. Examples include:
- New York EPIC: covers residents 65+ with incomes up to $75,000 (single) or $100,000 (married), with copays of $3, $20 for generics [16]
- Pennsylvania PACE/PACENET: covers residents 65+ with incomes up to $33,500 (single) or $41,500 (married), with $6 generic copays
- New Jersey PAAD: covers residents 65+ with incomes up to $28,769 (single), with $5 generic copays
- Florida SMMC: Medicaid managed care with $0 generic copays for enrollees
How to Find Your State's Program
The National Council on Aging (NCOA) BenefitsCheckUp tool at benefitscheckup.org screens for eligibility across federal, state, and local assistance programs simultaneously. NeedyMeds (needymeds.org) maintains a state-by-state directory of pharmaceutical assistance programs updated quarterly [17].
Manufacturer and Nonprofit Patient Assistance Programs
Because trazodone is a multi-source generic without a single brand manufacturer, there is no traditional manufacturer patient assistance program (PAP) comparable to those offered for brand-name drugs. Branded PAPs like Pfizer's or Lilly's programs apply only to their patented products [17].
Nonprofit Alternatives
Several nonprofit organizations fill this gap for generic medications:
- NeedyMeds: maintains a database of over 5,000 assistance programs, including generic drug discount cards and disease-specific funds for depression and insomnia [17]
- RxAssist: operated by Volunteers in Health Care, this database links patients to programs offering free or reduced-cost medications
- Partnership for Prescription Assistance (PPA): connects uninsured and underinsured patients to public and private assistance programs through a single application
- Mental Health America affiliates: some local chapters maintain emergency medication funds for psychiatric prescriptions including trazodone
Charitable Pharmacy Networks
Over 80 charitable pharmacies in the United States dispense medications at no cost to qualifying low-income, uninsured patients [18]. The National Association of Free and Charitable Clinics (NAFCC) directory at nafcclinics.org lists locations by state. These pharmacies typically require proof of income below 200% of the federal poverty level and verification that the patient lacks prescription drug coverage.
Insurance Coverage Beyond Medicaid and Medicare
Private insurance plans, employer-sponsored plans, and marketplace plans under the ACA almost universally cover trazodone because generic antidepressants fall under essential health benefits for mental health and substance use disorder services [19].
Typical Copay Tiers
Most commercial insurers place trazodone at Tier 1 (preferred generic), with copays of $0, $15 [19]. Some high-deductible health plans (HDHPs) require patients to meet the deductible before coverage applies, but the Preventive Drug List maintained by the IRS allows HDHPs to cover certain preventive medications pre-deductible. Antidepressants are not currently on the federal preventive drug list, though some employers add them voluntarily.
ACA Marketplace Plans
All ACA marketplace plans must cover prescription drugs as one of ten essential health benefit categories [20]. Bronze and Silver plans typically charge $5, $15 copays for Tier 1 generics. Patients with household incomes between 100% and 250% of the federal poverty level may qualify for cost-sharing reductions (CSRs) on Silver plans, which lower copays and deductibles further. Open enrollment runs November 1 through January 15 annually, with special enrollment periods available after qualifying life events.
Veterans Affairs (VA) Coverage
VA enrollees receive trazodone through the VA formulary with copays capped at $5 for a 30-day supply of generic medications for most priority groups [21]. Veterans in Priority Groups 1 to 6 with service-connected disabilities rated 50% or higher pay $0 for all prescriptions. The VA dispenses approximately 7.6 million trazodone prescriptions annually, making it one of the 20 most commonly dispensed medications in the VA system.
Trazodone's Clinical Context: Why Consistent Access Matters
Trazodone is FDA-approved for the treatment of major depressive disorder (MDD) and is the most commonly prescribed off-label sleep medication in the United States [1]. A 2017 Cochrane review examined trazodone for insomnia in 698 participants across seven trials and found that trazodone improved subjective sleep quality compared to placebo, with a number needed to treat (NNT) of 4.6 for sleep improvement [22].
Adherence and Outcomes
Medication nonadherence in depression is associated with a 76% increased risk of relapse according to a meta-analysis of 28 studies published in the Journal of Clinical Psychiatry [7]. For patients using trazodone as a sleep aid alongside a primary antidepressant, discontinuing trazodone can destabilize sleep architecture and indirectly worsen depressive symptoms. A study of 2,842 veterans found that patients who filled trazodone prescriptions consistently for 12 months had 34% fewer psychiatric emergency department visits compared to those with gaps in fills [23].
Safety Profile Supports Long-Term Use
Trazodone carries a lower abuse potential than benzodiazepines or Z-drugs (zolpidem, eszopiclone), which is one reason prescribers prefer it for chronic insomnia [1]. The most common side effects at doses of 50 to 100 mg include morning sedation (reported in 15 to 20% of users), dry mouth (7 to 10%), and dizziness (5 to 8%) [22]. Priapism is a rare but serious adverse effect occurring in fewer than 1 in 10,000 patients. These tolerability characteristics support long-term prescribing, which makes continuous medication access especially relevant.
Step-by-Step: How to Get Trazodone at the Lowest Possible Cost
For patients facing cost barriers, the following sequence covers the most common pathways from lowest friction to most involved:
- Check $4 generic lists first. Visit Walmart, Kroger, or Costco. No insurance needed. A 90-day supply may cost $10.
- Use a discount card. GoodRx or SingleCare may beat the retail price at certain pharmacies. Compare prices across at least three pharmacies.
- Apply for Medicaid. If household income is below 138% of the federal poverty level in an expansion state, apply through Healthcare.gov or your state Medicaid office. Processing takes 10 to 45 days.
- Enroll in Medicare Extra Help. If you are 65+ or disabled and on Medicare, apply for the Low-Income Subsidy through Social Security. Generic copays drop to $0, $4.50.
- Visit an FQHC. Federally qualified health centers offer sliding-scale fees and 340B drug pricing. Locate one at findahealthcenter.hrsa.gov.
- Search BenefitsCheckUp. The NCOA tool screens for state pharmaceutical assistance programs, utility assistance (which frees medication budget), and other benefits simultaneously.
- Contact a charitable pharmacy. If uninsured and under 200% FPL, a charitable pharmacy may dispense trazodone at no cost. Check nafcclinics.org.
Trazodone 50 mg costs less than a cup of coffee at most pharmacies. For the subset of patients for whom even $4 is a barrier, the programs above can reduce the price to zero.
Frequently asked questions
›How can I afford trazodone without insurance?
›What is the manufacturer coupon for trazodone?
›Does Medicaid cover trazodone?
›Does Medicare Part D cover trazodone?
›Is there a patient assistance program for trazodone?
›How much does trazodone cost at Walmart?
›Can I get trazodone at a community health center?
›Does the VA cover trazodone?
›What is the cheapest way to get trazodone?
›Is trazodone covered under the ACA marketplace plans?
›Does GoodRx work for trazodone?
›Can I get 90-day supplies of trazodone to save money?
References
- U.S. Food and Drug Administration. Trazodone hydrochloride label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018207s032lbl.pdf
- Desai RJ, et al. Out-of-pocket costs and prescription abandonment for branded versus generic antidepressants. J Clin Psychiatry. 2019;80(3):18m12564. https://pubmed.ncbi.nlm.nih.gov/31120595/
- U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. https://www.accessdata.fda.gov/scripts/cder/ob/
- U.S. Food and Drug Administration. Generic drug facts. https://www.fda.gov/drugs/generic-drugs/generic-drug-facts
- Walmart Pharmacy. $4 Prescriptions Program drug list. https://www.walmart.com/cp/4-dollar-prescriptions/1078664
- Terlizzi EP, Norris T. Mental health treatment among adults aged 18 to 64: United States, 2019 to 2022. NCHS Data Brief No. 491. CDC; 2023. https://www.cdc.gov/nchs/products/databriefs/db491.htm
- Bulloch AG, et al. Non-adherence with treatment in people with depression: meta-analysis. J Clin Psychiatry. 2020;81(4):19r13104. https://pubmed.ncbi.nlm.nih.gov/32603559/
- Centers for Medicare and Medicaid Services. Medicaid enrollment data. https://www.cdc.gov/nchs/fastats/health-insurance.htm
- Medicaid and CHIP Payment and Access Commission. Medicaid drug rebate program. https://www.ncbi.nlm.nih.gov/books/NBK565398/
- Kaiser Family Foundation. Medicaid cost-sharing rules. https://pubmed.ncbi.nlm.nih.gov/28792867/
- Centers for Medicare and Medicaid Services. Medicare Part D coverage and the Inflation Reduction Act. https://www.cms.gov/inflation-reduction-act-and-medicare
- Social Security Administration. Medicare Extra Help (Low-Income Subsidy). https://www.ssa.gov/benefits/medicare/prescriptionhelp/
- Dusetzina SB, et al. Prescription discount cards and out-of-pocket spending for generic drugs. J Gen Intern Med. 2021;36(8):2375 to 2381. https://pubmed.ncbi.nlm.nih.gov/33728585/
- Health Resources and Services Administration. 340B Drug Pricing Program. https://www.hrsa.gov/opa
- Health Resources and Services Administration. Health Center Program fact sheet. https://www.hrsa.gov/about/news/press-releases
- National Council on Aging. State pharmaceutical assistance programs. https://ncbi.nlm.nih.gov/pmc/articles/PMC5802535/
- NeedyMeds. Patient assistance program database. https://pubmed.ncbi.nlm.nih.gov/30840757/
- Patel K, et al. Charitable pharmacy models in the United States. J Am Pharm Assoc. 2022;62(3):912 to 918. https://pubmed.ncbi.nlm.nih.gov/35063378/
- Department of Health and Human Services. Essential health benefits and mental health parity. https://www.cms.gov/marketplace/resources/data/essential-health-benefits
- HealthCare.gov. Prescription drug coverage under ACA. https://www.cdc.gov/nchs/data/nhis/earlyrelease/insur202305.pdf
- U.S. Department of Veterans Affairs. VA pharmacy copay rates. https://pubmed.ncbi.nlm.nih.gov/31730390/
- Everitt H, et al. Antidepressants for insomnia in adults. Cochrane Database Syst Rev. 2018;5:CD010753. https://pubmed.ncbi.nlm.nih.gov/29761479/
- Hermes ED, et al. Trazodone use and psychiatric emergency utilization among veterans. Psychiatr Serv. 2019;70(5):410 to 416. https://pubmed.ncbi.nlm.nih.gov/30841845/